Cellebrite Stock Today


USD 4.64  0.15  3.34%   

Market Performance
0 of 100
Odds Of Distress
Over 73
Cellebrite is selling for under 4.64 as of the 26th of November 2022; that is 3.34 percent increase since the beginning of the trading day. The stock's last reported lowest price was 4.37. Cellebrite has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Cellebrite Di are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2022 and ending today, the 26th of November 2022. Click here to learn more.
Fiscal Year End
IPO Date
31st of August 2021
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 189.65 M outstanding shares of which 1.41 M shares are currently shorted by private and institutional investors with about 14.91 trading days to cover. More on Cellebrite Di

Moving together with Cellebrite

+0.67ADBEAdobe Systems TrendingPairCorr
+0.66SHOPShopify TrendingPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Cellebrite Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cellebrite's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cellebrite or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Cellebrite Di generated a negative expected return over the last 90 days
Cellebrite Di has high likelihood to experience some financial distress in the next 2 years
About 77.0% of the company shares are held by company insiders
Average Analyst Recommendation
Analysts covering Cellebrite report their recommendations after researching Cellebrite's financial statements, talking to executives and customers, or listening in on Cellebrite's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Cellebrite Di. The Cellebrite consensus assessment is calculated by taking the average forecast from all of the analysts covering Cellebrite.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Cellebrite's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cellebrite Di (CLBT) is traded on NASDAQ Exchange in USA and employs 900 people. The company currently falls under 'Small-Cap' category with current market capitalization of 879.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cellebrite's market, we take the total number of its shares issued and multiply it by Cellebrite's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Cellebrite Di conducts business under Technology sector and is part of Software—Infrastructure industry. The entity has 189.65 M outstanding shares of which 1.41 M shares are currently shorted by private and institutional investors with about 14.91 trading days to cover. Cellebrite Di currently holds about 146.54 M in cash with 14.63 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Check Cellebrite Probability Of Bankruptcy
Cellebrite holds a total of one hundred eighty-nine million six hundred fifty thousand outstanding shares. Cellebrite Di shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 76.86 percent of Cellebrite Di outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Cellebrite Ownership Details

Cellebrite Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Cellebrite jumping above the current price in 90 days from now is about 35.22%. The Cellebrite Di probability density function shows the probability of Cellebrite stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Cellebrite has a beta of 0.7318 suggesting as returns on the market go up, Cellebrite average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cellebrite Di will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Cellebrite Di is significantly underperforming DOW.
  Odds Below 4.64HorizonTargetOdds Above 4.64
64.59%90 days
Based on a normal probability distribution, the odds of Cellebrite to move above the current price in 90 days from now is about 35.22 (This Cellebrite Di probability density function shows the probability of Cellebrite Stock to fall within a particular range of prices over 90 days) .

Cellebrite Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Cellebrite that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cellebrite's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cellebrite's value.
InstituionSecurity TypeTotal SharesValue
Yarbrough Capital LlcCommon Shares53.5 K210 K
Yarbrough Capital LlcCommon Shares53.5 K273 K
Wolverine Trading LlcPut Options15 K76 K
View Cellebrite Diagnostics

Cellebrite Di Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cellebrite market risk premium is the additional return an investor will receive from holding Cellebrite long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cellebrite. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cellebrite's alpha and beta are two of the key measurements used to evaluate Cellebrite's performance over the market, the standard measures of volatility play an important role as well.

Cellebrite Stock Against Markets

Picking the right benchmark for Cellebrite stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cellebrite stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cellebrite is critical whether you are bullish or bearish towards Cellebrite Di at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cellebrite without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now


Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Invested in Cellebrite Di?

The danger of trading Cellebrite Di is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cellebrite is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cellebrite. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cellebrite Di is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Cellebrite Di information on this page should be used as a complementary analysis to other Cellebrite's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Cellebrite Stock analysis

When running Cellebrite Di price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Cellebrite's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellebrite. If investors know Cellebrite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellebrite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
879 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Cellebrite Di is measured differently than its book value, which is the value of Cellebrite that is recorded on the company's balance sheet. Investors also form their own opinion of Cellebrite's value that differs from its market value or its book value, called intrinsic value, which is Cellebrite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellebrite's market value can be influenced by many factors that don't directly affect Cellebrite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellebrite's value and its price as these two are different measures arrived at by different means. Investors typically determine Cellebrite value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellebrite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.